Error! You must have javascript enabled to use this form. Please enable Javascript in your browser. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Investor Notice: Investigation over Potential Wrongdoing Certain directors of Lexicon Pharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties. View full press release Your Name: Your Email: To Email: To BCC: Subject: Comments: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send